Physician profile
Maria Compton
NPI 1043506900
$6,871.96
in general payments reported to CMS, 2019-2025
12 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $41.62 · 2021: $257 · 2022: $177 · 2023: $479 · 2024: $5,448 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,800 · Food and Beverage: $1,891 · Travel and Lodging: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,800.00 |
| Food and Beverage | $1,891.01 |
| Travel and Lodging | $1,575.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,151.44 | 2022-2025 | Nuvent, Propel, Stealthstation S8 Platform |
| Inspire Medical Systems, INC. | $860.60 | 2023-2025 | Inspire |
| Stryker Corporation | $269.82 | 2019-2025 | Fiagon Navigation Unit, Latera |
| Genzyme Corporation | $192.33 | 2021-2022 | |
| Medtronic USA, INC. | $89.37 | 2019 | |
| Aerin Medical INC. | $70.36 | 2022-2025 | |
| Optinose US, INC. | $58.78 | 2019-2021 | |
| Organogenesis INC. | $46.83 | 2022 | |
| Neurent Medical Limited | $43.79 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Regeneron Healthcare Solutions, INC. | $39.97 | 2021-2022 | |
| Boston Scientific Corporation | $33.91 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $14.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Compton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.